Newborns with Favourable Outcomes after Perinatal Asphyxia Have Upregulated Glucose Metabolism-Related Proteins in

Ping K Yip1, Michael Bremang2, Ian Pike2

  • 1Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.

Biomolecules
|October 28, 2023
PubMed

Insights

Therapeutic hypothermia (TH) for hypoxic-ischaemic encephalopathy (HIE) shows promise, but its mechanism is unclear. This study found upregulated glucose metabolism proteins in newborns with favorable HIE outcomes after TH, suggesting new therapeutic targets.

Area of Science:

  • Biochemistry and Molecular Biology
  • Neonatal Medicine
  • Proteomics

Background:

  • Hypoxic-ischaemic encephalopathy (HIE) is a significant global cause of newborn morbidity and mortality.
  • Mild therapeutic hypothermia (TH) can improve outcomes in HIE, but its underlying mechanisms require further elucidation.

Purpose of the Study:

  • To investigate the plasma proteome of newborns with HIE undergoing TH to identify mechanisms of neuroprotection.
  • To compare protein profiles between HIE newborns with favorable and unfavorable outcomes following TH.

Main Methods:

  • Plasma samples from newborns with moderate-severe HIE (treated with TH), mild HIE (no TH), and normal controls (cord blood) were analyzed.
  • Isobaric Tandem Mass Tag (TMT®) 10plex™ labeling coupled with tandem mass spectrometry was employed for proteomic analysis.
  • Bioinformatic analysis, including Gene Ontology (GO) annotation and functional clustering, was used to interpret protein data.

Main Results:

  • A total of 405 proteins were identified, with distinct signatures differentiating normal cord blood from HIE groups.
  • Newborns with favorable outcomes (sHIE+) after TH showed significant upregulation of glucose metabolism-related enzymes compared to those with unfavorable outcomes (sHIE-).
  • Specific upregulated enzymes in the sHIE+ group included fructose-bisphosphate aldolase A, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase PKM, among others.

Conclusions:

  • Plasma proteomic analysis reveals an upregulation of glucose metabolism pathways in newborns with favorable outcomes following TH for HIE.
  • These findings suggest that enhanced glucose metabolism may be a key mechanism underlying the neuroprotective effects of TH.
  • The identified proteins may serve as potential biomarkers or therapeutic targets for improving neuroprotection strategies in HIE.

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
956
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
274
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
167
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K